Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs Eli Lilly And Co (LLY) Price & Performance

ARK Genomic Revolution ETFTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

ARK Genomic Revolution ETF vs Eli Lilly And Co — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Eli Lilly And Co trades at $1,214.93 (market cap $1.08T). The key difference: Eli Lilly And Co pays a 0.57% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.

ARKGLLY
Sector
Sector/ThematicHealth
52-Week High
$44.55$1.24K
52-Week Low
$24.02$639.43
Market Cap
$1.08T
Enterprise Value
$1.13T
Dividend Yield
0.57%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY